RESUMEN
BACKGROUND: Hypotension, increased production of reactive oxygen species, and inflammation are all observed in experimental models of sepsis induced by lipopolysaccharide (LPS). PURPOSE: The aim of this study was to evaluate the effects of an ethanolic extract of Brazilian olive leaf (Ex), Brazilian olive oil (Olv), Ex + Olv (ExOlv), and palm oil (Pal) in comparison to the effects of omega-3 fish oil (Omg) in a rat model of sepsis-induced acute kidney injury. MATERIALS: Wistar rats were divided into seven groups (seven per group), which were either untreated (control) or treated with LPS, LPS + Ex, LPS + ExOlv, LPS + Olv, LPS + Omg, or LPS + Pal. RESULTS: Lower values of creatinine clearance and blood pressure were observed in the LPS-treated group, and these values were not affected by Ex, Olv, ExOlv, Pal, or Omg treatment. Mortality rates were significantly lower in rats exposed to LPS when they were also treated with Ex, ExOlv, Olv, Pal, or Omg. These treatments also decreased oxidative stress and inflammation (Tumor necrosis factor alpha, interleukin-1 beta) and increased interleukin-10 levels and cell proliferation, which were associated with decreased apoptosis in kidney tissue. CONCLUSION: Ex and Pal treatments were beneficial in septic rats, since they increased survival rate and did not aggravate inflammation. However, the most effective treatments for septic rats were Olv in comparison to Omg. These natural food substances could enable the development of effective therapeutic interventions to sepsis.
RESUMEN
Xanthine oxidase activation occurs in sepsis and results in the generation of uric acid (UrAc) and reactive oxygen species (ROS). We aimed to evaluate the effect of xanthine oxidase inhibitors (XOis) in rats stimulated with lipopolysaccharide (LPS). LPS (10 mg/kg) was administered intraperitoneally (i.p.) immediately after allopurinol (Alo, 2 mg/kg) or febuxostat (Feb, 1 mg/kg) every 24 h for 3 days. To increase UrAc levels, oxonic acid (Oxo) was administered by gavage (750 mg/kg per day) for 5 days. Animals were divided into the following 10 groups (n = 6 each): (1) Control, (2) Alo, (3) Feb, (4) LPS, (5) LPSAlo, (6) LPSFeb, (7) Oxo, (8) OxoLPS, (9) OxoLPSAlo, and (10) OxoLPSFeb. Feb with or without Oxo did not aggravate sepsis. LPS administration (with or without Oxo) significantly decreased the creatinine clearance (ClCr) in LPSAlo (60%, P < 0.01) versus LPS (44%, P < 0.05) and LPSFeb (35%, P < 0.05). Furthermore, a significant increase in mortality was observed with LPSAlo (28/34, 82%) compared to LPS treatment alone (10/16, 63%) and LPSFeb (11/17, 65%, P < 0.05). In addition, increased levels of thiobarbituric acid reactive substances (TBARS), tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 were observed at 72 h compared to the groups that received LPS and LPSFeb with or without Oxo. In this study, coadministration of Alo in LPS-induced experimental sepsis aggravated septic shock, leading to mortality, renal function impairment, and high ROS and proinflammatory IL levels. In contrast, administration of Feb did not potentiate sepsis, probably because it did not interfere with other metabolic events.
Asunto(s)
Alopurinol/toxicidad , Inhibidores Enzimáticos/toxicidad , Febuxostat/toxicidad , Sepsis/inducido químicamente , Sepsis/tratamiento farmacológico , Xantina Oxidasa/antagonistas & inhibidores , Animales , Apoptosis/efectos de los fármacos , Modelos Animales de Enfermedad , Interleucina-10/sangre , Interleucina-6/sangre , Riñón/efectos de los fármacos , Riñón/enzimología , Riñón/patología , Lipopolisacáridos , Masculino , Ácido Oxónico/farmacología , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Sepsis/sangre , Sepsis/enzimología , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factores de Tiempo , Factor de Necrosis Tumoral alfa/sangre , Ácido Úrico/metabolismo , Xantina Oxidasa/metabolismoRESUMEN
INTRODUCTION: There is little information in the literature relating supplementary oral usage of vitamin D and calcium to the development of kidney stones. OBJECTIVE: To evaluate the effect of high dose, 200 IU of vitamin D3 (V) with calcium supplementation (Ca). METHODS: Experimental model consists of insertion of pellets into the bladder of rats. V was administered for 30 days with or without Ca. The rats were divided in 6 groups: 1. Sham, 2. Pellets control; 3. V control; 4. Pellets + V; 5. Pellets + Ca and 6. Pellets + Ca + V. RESULTS: 50% and 17% decreases bladder stones formation in groups 5 and 6, p < 0.005 comparing with the group 2 were observed. There was no hypercalcemia or hypercalciuria in all groups. We observed a significant decrease in calciuria in group 6 (p = 0.03). CONCLUSION: The administration of the V associated with Ca significantly decreased the formation of stones and caused a significant reduction in urinary calcium, suggesting a protection in the lithogenic pathophysiology.
Asunto(s)
Calcio/administración & dosificación , Colecalciferol/efectos adversos , Nefrolitiasis/inducido químicamente , Vitaminas/efectos adversos , Animales , Colecalciferol/administración & dosificación , Suplementos Dietéticos , Modelos Animales de Enfermedad , Sobredosis de Droga , Ratas , Ratas Wistar , Vitaminas/administración & dosificaciónRESUMEN
Introdução: Há poucos dados na literatura sobre a suplementação de vitamina D e cálcio e o desenvolvimento de cálculos renais. Objetivo: Avaliar o efeito de doses elevadas de vitamina D3 (V), com suplemento de cálcio (Ca) no desenvolvimento de litíase em modelo experimental. Métodos: Pastilhas foram inseridas na bexiga de ratos, que receberam V com ou sem Ca. Ratos foram divididos em seis grupos: 1. Sham; 2. Controle com pastilha, 3. Controle com V, 4. Pastilha + V, 5. Pastilha + Ca e 6. Pastilha + Ca + V. Resultados: Observou-se 50% e 17% de redução na formação de cálculos, respectivamente nos grupos 5 e 6 em comparação ao grupo 2 (p < 0,005). Não foram observadas hipercalcemia ou hipercalciúria em todos os grupos. Encontramos no grupo 6 (p = 0,03) uma redução significativa na calciúria. Conclusão: A administração de V associada com Ca diminuiu significantemente a formação de cálculos e reduziu significantemente a calciúria, sugerindo uma interferência benéfica na fisiopatologia litogênica. .
Introduction: There is little information in the literature relating supplementary oral usage of vitamin D and calcium to the development of kidney stones. Objective: To evaluate the effect of high dose, 200 IU of vitamin D3 (V) with calcium supplementation (Ca). Methods: Experimental model consists of insertion of pellets into the bladder of rats. V was administered for 30 days with or without Ca. The rats were divided in 6 groups: 1. Sham, 2. Pellets control; 3. V control; 4. Pellets + V; 5. Pellets + Ca and 6. Pellets + Ca + V. Results: 50% and 17% decreases bladder stones formation in groups 5 and 6, p < 0.005 comparing with the group 2 were observed. There was no hypercalcemia or hypercalciuria in all groups. We observed a significant decrease in calciuria in group 6 (p = 0.03). Conclusion: The administration of the V associated with Ca significantly decreased the formation of stones and caused a significant reduction in urinary calcium, suggesting a protection in the lithogenic pathophysiology. .
Asunto(s)
Animales , Ratas , Calcio/administración & dosificación , Colecalciferol/efectos adversos , Nefrolitiasis/inducido químicamente , Vitaminas/efectos adversos , Colecalciferol/administración & dosificación , Suplementos Dietéticos , Modelos Animales de Enfermedad , Sobredosis de Droga , Ratas Wistar , Vitaminas/administración & dosificaciónRESUMEN
Objetivo: Relatar seis casos de Aids em crianças cujo diagnóstico ocorreu tardiamente. Descrição: são descritos os principais sinais e sintomas apresentados desde o nascimento incluindo infecções de repetição (especialmente pneumonias), diarréia crônica, linfadenopatia generalizada, atraso de desenvolvimento neuropsicomotor...
Objective: to report six cases of Aids in Children with late diagnosis. Description: main signs and symptoms presented since birth are described including repetitive infecction (especially pneumonias), chronic diarrhea, generalized lymphadenopathy...